Find a Clinical Trial
Each time a person with lung disease faces a treatment decision, it is important to explore all options. The American Lung Association recommends that you consider clinical trials as soon as you are diagnosed and every time you have to make a treatment decision.
Clinical trials are carefully monitored scientific research studies. Regulated in the United States by the Food and Drug Administration (FDA), they test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease.
We want you to be aware of all treatment opportunities. Learn more about clinical trial programs in your area by searching below and be sure to discuss with your doctor whether a clinical trial is right for you.
If you are an institution and would like to list your study on our websites, please view Register Your Clinical Trials with the American Lung Association.
Refine your search:
Sorry, no results were found.
- Trial of Roflumilast in Asthma Management (TRIM) May 1, 2017 - April 30, 2020 Disease: Asthma
- Asthma BMI Baseline Study (ABBS) Disease: Asthma
- Parental Response Using a Daily Digital Diary to Capture Respiratory Symptoms in Young Children with Recurrent Respiratory Tract Illnesses (American Lung Association [ALA] Novel Digital Diary [ANDDi]) Disease: Asthma
- Losartan Effects on Emphysema Progression (LEEP) Trial May 1, 2015 - December 31, 2019 Disease: COPD
- Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) October 1, 2019 - October 1, 2021 Disease: Asthma
- Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400) June 16, 2014 - January 1, 2022 Disease: Lung Cancer
- Lung Cancer Study January 1, 1996 - January 1, 2022 Disease: Lung Cancer
- Genetic Epidemiology of Lung Cancer April 26, 2003 - January 31, 2021 Disease: Lung Cancer
- MANDALA December 27, 2018 - December 1, 2020 Disease: Asthma
- Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis September 5, 2019 - July 1, 2025 Stanford, California Disease: Pulmonary Fibrosis
Disclaimer: This is offered as a service to our constituents. The American Lung Association does its best to screen trials so that they meet our standards. However, the American Lung Association cannot assume any responsibility for any aspect of the individual trials including any adverse events which may be encountered as a result of the trial.
Sign up for the latest lung health news sent right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.